ENTX
Entera Bio: 2025 Annual Financial Summary
Company Overview Entera Bio is a clinical-stage leader developing oral peptide therapies, specifically focusing on its N-Tab® platform. Its lead…
Entera Bio Ltd (ENTX) Q1 2022 Earnings conference call
Entera Bio Ltd (NASDAQ: ENTX) Q1 2022 Earnings Conference
Entera Bio Ltd (ENTX) Q2 2021 EARNINGS CONFERENCE CALL
Entera Bio Ltd (NASDAQ: ENTX) Q2 2021 Earnings Conference
Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call Transcript
Entera Bio Ltd. (NASDAQ: ENTX) Q4 2020 earnings call dated Mar. 18, 2021 Corporate Participants: Jonathan Lieber — Chief Financial…
Entera Bio Ltd (ENTX) Entera Bio Ltd Announces Operating and Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Entera Bio Ltd (NASDAQ: ENTX) Q4 2020 Earnings Conference